Gene therapy firm Targeted Genetics Corp. is boosting its cash position through a $19.5 million private placement of 6.7 million shares priced at $2.91 each to fund ongoing development activities. (BioWorld Today)

Gene therapy firm Targeted Genetics Corp. is boosting its cash position through a $19.5 million private placement of 6.7 million shares priced at $2.91 each to fund ongoing development activities. (BioWorld Today)